Alcon (ALC) Cash from Financing Activities (2009 - 2026)
Alcon (ALC) posted quarterly Cash from Financing Activities of -$133.0 million for Q1 2026, up 59.7% on a QoQ basis from -$330.0 million in Q4 2025.
Alcon (ALC) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Alcon (ALC) has reported Cash from Financing Activities for 11 consecutive years, with -$133.0 million the latest figure, recorded in Q1 2026.
- Quarterly Cash from Financing Activities changed N/A year-over-year to -$133.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.2 billion (changed N/A YoY) and the FY2025 annual result came in at -$1.1 billion, down 247.52% from the prior year.
- Cash from Financing Activities improved to -$133.0 million in Q1 2026 per ALC's latest filing, from -$330.0 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for ALC reached as high as $281.0 million in Q4 2022 and fell as low as -$383.0 million in Q2 2025.
- A 5-year average of -$106.1 million and a median of -$85.0 million in 2022 frame the typical range for Cash from Financing Activities.
- Annual changes were most pronounced in 2022 — Cash from Financing Activities soared 951.52% — and 2025, when it tumbled 8150.0%.
- Year by year, Cash from Financing Activities stood at $281.0 million in 2022, then slumped by 119.57% to -$55.0 million in 2023, then soared by 92.73% to -$4.0 million in 2024, then slumped by 8150.0% to -$330.0 million in 2025, then surged by 59.7% to -$133.0 million in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$133.0 million, -$330.0 million, and -$310.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -11.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -133.00 Mn |
| Mar 31, 2026 | -133.00 Mn |
| Dec 31, 2025 | -330.00 Mn |
| Dec 31, 2025 | -330.00 Mn |
| Sep 30, 2025 | -310.00 Mn |
| Sep 30, 2025 | -310.00 Mn |
| Jun 30, 2025 | -383.00 Mn |
| Jun 30, 2025 | -383.00 Mn |
| Dec 31, 2024 | -4.00 Mn |
| Dec 31, 2024 | -4.00 Mn |
| Sep 30, 2024 | -81.00 Mn |
| Sep 30, 2024 | -81.00 Mn |
| Jun 30, 2024 | -171.00 Mn |
| Jun 30, 2024 | -171.00 Mn |
| Mar 31, 2024 | -66.00 Mn |
| Mar 31, 2024 | -66.00 Mn |
| Dec 31, 2023 | -55.00 Mn |
| Dec 31, 2023 | -55.00 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Sep 30, 2023 | 10.00 Mn |